AFF3 (AF4/FMR2 family, member 3) was recognized as a master regulator of metabolic inflexibility in type 2 diabetes (Son et al. 2019) and was associated with serum lipid alterations and blood triglyceride levels (Li et al. 2015). This evidence concerns the gene AFF2 and type 2 diabetes mellitus.